New York State Common Retirement Fund
IMRX icon

New York State Common Retirement Fund’s Immuneering IMRX Stock Holding History

New York State Common Retirement Fund’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-209
Closed -$268 – 3268
2024
Q2 		$268 Sell
209
-9,460
-98% -$15.6K ﹤0.01% 3367
2024
Q1 		$27.9K Buy
9,669
+574
+6% +$3.22K ﹤0.01% 3108
2023
Q4 		$66.8K Sell
9,095
-41
-0.4% -$273 ﹤0.01% 2906
2023
Q3 		$70.2K Buy
9,136
+236
+3% +$2.17K ﹤0.01% 2896
2023
Q2 		$90.2K Buy
+8,900
New +$85.6K ﹤0.01% 2942
2022
Q3 		– Sell
-165
Closed -$1K – 3360
2022
Q2 		$1K Sell
165
-4,472
-96% -$23.9K ﹤0.01% 3363
2022
Q1 		$30K Hold
4,637
– – ﹤0.01% 3252
2021
Q4 		$75K Buy
4,637
+2,937
+173% +$71.5K ﹤0.01% 3146
2021
Q3 		$45K Buy
+1,700
New +$45.7K ﹤0.01% 3257

Other funds holding IMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

New York State Common Retirement Fund's IMRX Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Immuneering (IMRX) in Q3 2024, closing a stake of 209 shares — an estimated $268 sold.

New York State Common Retirement Fund first reported a position in IMRX in Q3 2021 and held it in 9 quarters. The position peaked at $90.2K in Q2 2023. 38 funds tracked by Wall St. Rank hold IMRX as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Immuneering position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 209 Immuneering shares in Q3 2024, an estimated $268.
  • New York State Common Retirement Fund first reported a position in Immuneering in Q3 2021 and held it in 9 quarters.
  • New York State Common Retirement Fund's Immuneering position peaked at $90.2K in Q2 2023.
  • 38 funds tracked by Wall St. Rank held Immuneering as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.